0
0 (0%)
Cassava Sciences Inc [PTIE]
Source:
Company Overview
Cassava Sciences, Inc. is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat central nervous system disorders, such as Alzheimer’s disease and Tuberous Sclerosis Complex (TSC)-related epilepsy.
| Country | United States |
| Headquarters | austin, texas |
| Phone Number | (512) 501-2444 |
| Industry | manufacturing |
| CEO | Richard J. Barry |
| Website | www.cassavasciences.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-141.4 |
| Net Income | $-24.3 |
| Net Cash | $7.4 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -15.8% |
| Profit as % of Stockholder Equity | -16.7% |
Management Effectiveness
| Return on Equity | -16.7% |
| Return on Assets | -15.5% |
| Turnover Ratio | |
| EBITA | $-141.4 |
Balance Sheet and Cash Flow Measures
| Total Assets | $157.5 |
| Total Liabilities | $11.8 |
| Operating Cash Flow | $-116.9 |
| Investing Cash Flow | $-0.1 |
| Financing Cash Flow | $124.5 |
